Post Hoc News Today

he probably has to shoulder some of the blame for some of the things that got wrong. some might think its a bit rich, given the fact that he was thought to have broken the spirit of lockdown rules at a really critical point in the first lockdown, and that sent out a particular message to the public. so id do think some of this is just people lining themselves up, you know, putting blame on other people, taking some of the credit for themselves. i think coming back to themselves. i thin...

/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company and its partners will present 14 abstracts from across its sleep...

The study examined how vitamin D levels and vitamin D binding protein genotypes in both pregnant mothers and their children aged 3-5, impact early childhood neurodevelopment. Findings suggest that higher vitamin D concentrations in children were associated with better neurodevelopmental scores, with additional influences from sociodemographic factors and certain genetic variations.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q2 2023 Earnings Call Transcript August 3, 2023 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $10.24, expectations were $9.92. Operator: Welcome to the Regeneron Pharmaceuticals Second Quarter 2023 Earnings Conference Call. My name is Shannon and I will be your operator for today’s call. At this time, all participants […]

The effects of the Mediterranean Diet (Med Diet) and intentional weight loss (IWL) on the gut microbiome.

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...

And with me is msnbc legal analyst lisa ruben, and punch bowl msnbc political contributor, jake sherman, to talk about the way congress looks. >> julia got into the stakes. im hoping you can expand on that and what your reading was of these arguments today. >> i think julia pretty much laid out the map. in some sense, its so strange that we just spent three hours, katy, listening to a lawsuit that is kind of post hoc fan fiction about a rehnquist opinion that got two other votes in bush v. gore ...

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that data from its robust migraine portfolio will be presented at the 16th European Headache Federation...

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced it would present new data across its rheumatology portfolio, including RINVOQ® (upadacitinib) for...

Thirty-six abstracts underscore AbbVies commitment to advancing research to help more people living with rheumatic diseasesAdditional analysis of...